Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

DGAP-Adhoc: CompuGroup Medical SE: Annual General Meeting approves the change of legal form into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA)

eqs_en 
0 0 13.05.20
DGAP-Adhoc: CompuGroup Medical SE: Annual General Meeting approves the change of legal form into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA)
 

DGAP-Ad-hoc: CompuGroup Medical SE / Key word(s): AGM/EGM
CompuGroup Medical SE: Annual General Meeting approves the change of legal form into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA)

13-May-2020 / 15:49 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The Annual General Meeting of CompuGroup Medical SE of today has approved the change of legal form of the company, as proposed by the Management Board and the Supervisory Board, into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA) under the name "CompuGroup Medical SE & Co. KGaA". The general partner is CompuGroup Medical Management SE, a monistically structured European Stock Corporation (Societas Europaea, SE), which is held by the founder of the company and Chairman of the Management Board, Mr. Frank Gotthardt, as the controlling shareholder.

The participation of the shareholders in the company will not change as a result of the change of legal form. They will hold the same number of no-par value shares in the KGaA as they hold today, prior to the change of legal form, in CompuGroup Medical SE. The aggregate number of shares issued will also remain unchanged. The change of legal form will become effective upon registration with the commercial register.




Contact:
Claudia Thomé
Head of Investor Relations
CompuGroup Medical SE
email: [email protected]
phone +49 261 8000 7030
phone +49 261 8000 6200

13-May-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: CompuGroup Medical SE
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 6200
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE0005437305
WKN: 543730
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1044021

 
End of Announcement DGAP News Service

1044021  13-May-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1044021&application_name=news&site_id=sharewise

CompuGroup Medical SE Stock

€68.25
-0.730%
The price for the CompuGroup Medical SE stock decreased slightly today. Compared to yesterday there is a change of -€0.200 (-0.730%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the CompuGroup Medical SE stock is not clear.
As a result the target price of 74 € shows a slightly positive potential of 8.42% compared to the current price of 68.25 € for CompuGroup Medical SE.
Show more
Like: 0
Share
eqs_en 
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments

Not a member yet? Sign up for free!